Inuodutüon
The produets of the extreme polymorphic genetic Systems, which aie called major histocompatibihty complexes (MHC), play important roles in the immune system Α number of immune response (Ir) genes which regulate the level of response to specific antigens have been mapped to the same region MHC molecules participate in the interaction of Τ cells with foreign antigens, possibly providing binding Sites for foreign struetures such as viruses and soluble antigens and thus permitting their successful recognition by Τ cells T-cel) interaction with antigen IS MHC-restncted, which implies that Τ cells must possess reeeptors which simultaneously recognize both the self-MHC molecule and the foreign antigen Dunng the last decade expenmental evidence for this phenomenon has been widely reported in mouse and man
In this chapter, in vitro observations are desenbed concermng the recognition of human minor transplantation antigens by cytotoxic Τ cells in and Implikation ol Human Vlinor Η \ntigens 4t hc context ot sell-MHC The antigens recognt/ed in the '\stcms descnbcd below arc the male histocompatibiht\ antigen. H-Y. and other mmor lnstocompatibilitv aniigens In both cases. the class-[ mole< wies of thc MHC are tnvolved in ihe interactions of the effector evtotoxie Γ cells with thcn targets Detatled analvses of these Systems using cell lmes and cloncs ha\c shown that human c>totoxtc Τ cells recognize antigens in a manner analogous to that of cytotoxic Τ cells in the mouse. We have taken advantage ol the a\ailabiht\ of cells from bone marrow-grafted patients which had been pnmed to mmor histocompatibihty antigens in vivo in Order to stud> the role of evtotoxie Τ cells in ihcir recognition The results of the in \itio studies of patient matenal allowed us to draw some conclusions towaids its clinical rcle\ance and hopefull> can contnbute to the understanding of the role of non-MHC antigens in organ transplantation
Cell-Mediated L\ mp/ioh s/s Τ cells are \ery heterogeneous in function as well as in expression of surface markers Onh one of the T-cell subsels, namely the T-effectoi cells will bediscusscd This T-cell subset can be furtherdividcd into functionalh different T-effector cell subpopulations, of which the cytotoxic Τ Kmphoc>tes (CTLs) will bc desenbed below.
In the early modeis of cell-mediated lmmunity the effector populations were obtained from expenmental animals or humans who had been lmmunologically challengcd in vivo. Immunizations with allogeneic matcnals usually resulted in high levels of cytotoxicity and they can serve as a model for the analysis of transplantation. One of the best characten/ed effector cells in these in vivo allogeneic modeis is the CTL [19] . The first unequivocal observation of lymphocyte-mediated cytotoxicity was made b\ (7m-aeits [46] who observed that thoracic duet lymphocytes, harvested from dogs which had rejeeted their kidney allograft, were capable of lysing donor cells in vitro. Subsequent observations have confirmed the generahty of that findmg, and the lymphocyte-mediated destruction of many different target cells have been reported [89] .
In man, similar studies were reported in situations where allogeneic sensiti7ation oecurred in vivo For obvious ethical reasons, the need for a homologous in vitro system to replaee the in vivo sensitization
Step was clear The availabihty of an in vitro technique for thc induction and differentiation of specific cytolytic effector Τ cells has made a sigmficant contn- Goulm\ 46 buuon lo ihe undcrstanding of thc role oi the MHC antigens in thc immune responscand has pio\ided an in vitro model ofthc homograh reaetion The so-called cell-mediatcd lvmphohsis (CML) technique was developed b\ Li^htboch et a! [70] and consists of two in vitro phases an induction phase in which KmphoKtic effector cells are induccd and an effectoi phase in which the effector cells lvse chromium-labcled target cells Thc gcncration of effector cells in the first step IS necessarv in oider to obtam measuiable cvtotovicitv in the second step In addition thev used hmphocvtes transtormed into blasts bv treatment vvith phvtohemagglutinin as thc source ot target cells The CML assav asjust desenbed used relativel\ laige numbers of cells but a micromethod was introduced where the cells were incubated in plates [102] The disadvantage of this svstem was that at the end ot the incubation penod the supematant from each well had to be remo\ ed foi gamma counting This disadvantage was abolished bv the technical nnprovement for harvesting the supernatants in the CML assa\ with a simple cartndge svstem [51] Precise details of the method currentlv used in our laboraton» to detect evtotoxie T-cell responses in vitro have been given elsewhere [40] Recogmtion Stmctures foi C\toto\it 7 L\mphot\tes Class-I Molecules Class-I molecules (H-2K. D and L in the mouse, and HLA-A Β and C in man) are transmembrane glycoproteins with a molecular weight of 44 000 daltons The major portion of the molecules is on the outside of the cell membrane and is associated with a 12,000-dalton polvpeptide called ßi-microglobuhn The genetic analysis of the HLA complex was facihtated by Computer analvses of reaction patterns obtained from large numbers of antisera tested against random leukocyte samples [95] Recogmtion of the multiple alleles of the three HLA class-I loci was facihtated by a senes of international cooperative Workshops Recently, also biochemical anal>sis of the gene produets of the class-I loci demonstrated a senes of 44,000-dalton glycoprotein chains [116] , showing the presence of more than three class-I-like struetures Whether these can serve as recogmtion struetures for CTLs is unknown The class-I molecules can serve as target determinants for CTLs This is presumed since target determinants recognized in CML are highly associated with the serologically defined HLA specificities [16 26, 47-49, 69, 80, 113] and, in addition, demonstrated by the use of a Recognition and Implication of Human Minor Η Antigens -P human Β lvmphoblastoid ccll hne which lacked the serologically defincd HLA-A2 antigcn and had lost susceptibihty to lysis by HLA-A2-specific CTLs [2] Whether or not alloantisera and CTLs recogmze the same epitopes on class-I molecules IS a topic of current investigation and will be discussed bnefly in this chapter
Class-II Molecules
The class-II molecules (H-2 I region products in the mouse and HLA-D region products in man) consist of two separate glycoprotein chains with molecular weights of approximatelv 34,000 and 28,000 daltons Both chains are integral membrane proteins and have a large extracellular and a small intracellular region The products of the class-II genes are maml> responsible for the prohferative responses in mixed lymphocyte culture They can be identified b> serological as well as cellular techniques At least three distinct human class-II molecules exist HLA-DR, DC and SB [53] Recently analysis of the HLA-D region at the molecular and DNA level became possible and will lead to the further charactenzation of the class-II molecules [53, 99] It is possible to detect cytotoxicity towards class-II HLA-D/DR antigens or determinants closely linked to them [1, 27 55 76] and to DC antigens [109] das·;-! lanants In 1965 Baile\ and Kohn [3] provided the earhest evidence of H-2 gene mutation by the discovery of lncompatibilities within inbred strains In mbred strains of mice, individuals were found that were capable of rejecting skin grafts from mice of the same strain The generation and detection of these mutants has been reviewed [59] Α rather high rate of mutations is observed for the H-2K allele [60] Structural differences in the bm senes of mutants of the H-2K allele ha\e been shown by biochemical analysis [84] At the functional level, the differences have been confirmed by skin grafting and functional assays such as CML [4, 78, 79, 120] Evidence has been presented for the occurrence of analogous mutations in man In 1976, individual Variation within a serological defined specificny, ι e HLA-Bw 35, could bedetected by CTLs [35] CTLs were generated, between HLA-A, Β and C identical sibhngs, which specifically recognized two different types of HLA-Bw35 antigenic determinants which are still serologically indistinguishable Subsequently, by the use of CTLs, subtypes (vanants) 7 ""ι "^ 96 97 106] The nature of these non-HLA target du rminants lecogni/ed b\ in vitro CTLs could however not be deduced 1t s possible that some of these icactions lepresent vanants It seems hkely that CTLs specific for non-HL\ antigens will oeeur following in vivo immunization ι e as a result ot blood transfusion pregnancv graft rejection and graft-versus-host attack and the chance of finding non-HLA antigen-specific CTLs mav be increased in those situations With the use of in vivo generated CTLs a numbei of leports desenbed membrane diffeiences detected bv CML but not detected b\ conventional HLAt\ping[2i 29 11-33 16 42 54 68 ~*4 75 88 90 106a 112 114 117 118 121 122] Thc natuie of some ol these target determinants recognized b> in vivo generated CTLs and the mechanism bv which thev can be recognized will be discussed below
\1HC Rest na ίο η of CTLs
Histon and Models Oldstone et al [85] desenbed Variation in susceptibihtv to infection vuth lymphocvtic chonomeningitis virus (LCMV) in congeneic mice differmg only at H-2 (H-2q mice were more susceptible than H-2k mice ) These vanations to LCMV (which is apparently a T-cell-mediated lmmunopathological process) may be due to genetically determined differences in T-cell responsiveness The original expenment by Zinkemagel and Doheitx [123] established the fundamental importance of the role of the MHC in T-cellmediated lmmunity namely, virus-immune Τ cells obtained from LCMVmfected mice showed only in vitro cytotoxic activity when assayed on H- 2-compatiblc LCMV-mfecled fibroblasts argcl cells from H-2-incompatiblc donors were not Ivscd [123] Dunng thc following vcars numerous studies in rodents ha\e shown that thc activation of Τ hmphocvtes b\ different forcign antigens IS restncted bv self-MHC molecules Thus Τ lvmphocytes appear mainlv to be able to recogni/e forcign antigens when the\ are presentcd to thc Τ l\m-phocvtes on cells which share some homolog\ of the H-2 region vuth thc animal under study
The observations with LCMV were soon confirmed and seemed to be also applicable to a senes of other viruses ectromeha (mouse pox) vaccm1a sendai mfluen/a herpes simian (SV40), cytomegalo, alpha viruses and also for tumor-associated viruses [for review see ref 124] The H-2-rcstnction phenomcnon was not hmited to vnuses only Independcnth and at thc same time as /mkeinagel and Dohcrt\ [123] , Shearei [101] disco\ered in 1974 that MHC-restncted T-cell-mediated cytotoxicit> can be gencrated agamst svngeneic Kmphoid cells whose surfaces had been chemicalK modlfied MHC restnction of CTLs was also found for non-H-2 alloantigens ι c minor histocompatibihty antigens [6], including the male specific H-Y antigen [34] These reports and the manv which followed, show that a main function of class-I molecules is to participate in the interaction of CTLs with their targets MHC restnction is not unique to cytotoxic Τ cells as discussed extensively elsewhere in this volume
The underlying mechanism by which cytotoxic Τ cells recogm/e self-MHC and foreign antigen can be explained by two distinct modeis (a) the altered-self model, and (b) the double-receptor model In addition several other modeis shanng some of their features have been proposed In the altered-self model Τ cells are equipped with a Single receptor which is specific for a neoantigenic determinant formed by a complex of self-MHC and foreign antigen on the target cell, or one receptor for the complex of the unaltered-MHC molecule and antigen In the two T-cell receptor model Τ cells have two recognition molecules one is specific for self-MHC restnction molecule and the other tor foreign antigen This is called the dual recognition hypothesis The current thoughts about the two modcls have been recently summanzed by Berzofski [5] The first clear demonstration of the involvement of products of the human MHC in T-cell-mediated cytotoxicity was reported by our own group [36, 37] and concerned the recognition of the male-specific minor histocompatibihty antigen, H-Y Subsequently, HLA-restncted cytotoxic T-cell responses have been descnbed for \iralh infected taiget cells hke Epstein-Barr virus [94 115 The lole ol the tlass-I moleculcs and the thmcal implitalion ol tlu aη11 -\ 11 a 1 CTL iesponses are treated in more detail clsewhere in ihis \ol-ume The HLA-restutted CTL responses agamst minoi histotompatibilm (1 e minor H) antigens will be rcwewed below and are based on our expeiiments done over the last \eais on the detection ot minoi Η antigens and then possible implitations in human oigan transplantation In vitro immune response against the human male spetific histocompatibiht\ antigen H-Y was detected in a multi-transfused iemale aplasiic ancmia patient 1 e patient 1 She received a bone marrow graft from her HLA-identical brother There was a temporarv take but the graft was rejetted after 20 da\s Rejection was aecompanied by a ->pontaneous reco\ -cr\ of the patient's bone marrow hemopoietic function Investigation b> the use of the CML technique showed unambiguouslv that the post-transplant penpheral blood lymphocytes (PBLs) of this patient (le patient 1 HLA phenotype HLA A2, A2, Bw44, Bw60 Cw3 Cw5 DR4 DRw6) exhibited strong cell-mediated cy totoxic reactions specific for male HI A-A2-positive target cells [36, 37] (1) HLA-A2 vanants [41 45 ] and (2) abnormal sex chron nsome constuutions [43] J The le\el of Ksis IS low but significant numbers of T-ccll clones ma> have been directed against other minor Η antigens The presence of these minor Η antigens in the males may ha\e been masked b> the H-Y-specific lysis On the other hand, we ma> be dealmg with the phenomenon 'neoantigens can resemble alloantigens' It has been shown thai Τ cells which show antigen-specific MHC-restncted reactivit\ can also demonstrate cross-reactivity Namely, MHC-restncted CTLs can recognize not only modified seif but also histoincompatible (i e forcign) MHC molecules and/or modified foreign MHC molecules This obser\ation is often referred to as 'the seif plus foreign («neoantigen) resembles allo' phenomenon [10, 71] In our stud> all 3 women also had, in addition to HLA-A2, the HLABw60 antigen in common Analysis on the clonal level of the reactivitv patterns of the HLA-A2-restncted anti-H-Y CTLs against these HLABw60-positive female donors may provide us with more definitive answers It is worth noting that the level of HLA-A2-restncted anti-H-Y lysis seemed to dechne with time and the gradual waning seemed to be associated with the patient's reeovery Nevertheless, it was possible to restimulate the H-Y-specific lysis by an in vitro Stimulation using lymphocytes from an HLA-A-, B-, C-and D-identical unrelated male donor, instead of the HLAldentical male sibling donor cells. In that way effector cells were formed with the expected specificity for HLA-A2 male target cells. By using this Goulrnv ^2 piotocol A2-restncted H-Y-specific CTLs can bc obtaincd up to the prcsent timc -8 vears after gratting Our first observation was tonlu med in 2 additional cascs (out of a group of 12 femaie aplastic anemia paiicnts sludied) which showed cxactiv the same phcnomenon nameh HLArestnctcd anti-H-Y immunity [38. 39] These 2 cases (patients 2 and 1) weie femaie siblings with severe aplastic anemia They had boih been lmmuni/ed b\ multiple blood transfusions (and not by bone mairow transplantation) and in addition patient 2 had had three pregnancics The pattein ol Ksis obtained with effector cells of patient 2, after restimulation in \itio with the lymphocytes from her healthy HLA-identical male sibhng showed HLA-A2-restncted H-Y kilhng comparable to that in our first case reported earher Thus η follows that blood transfusions and possibly piegnancies are sufficient in themselves to induce HLA-restncted anti-H-\ c\totoxicit\ and that bone marrow transplantation IS not a necessary prerequisite [38] Singal et al [104] demonstrated the presence of HLA-A2-rcstncled anti-H-Y CTLs in multiparous females
In vitro studies with the lymphocytes ofour 3rd patient re\ealed HLArestncted CML reactivity to the H-Y antigen in which the self-HLA-A2 oi HLA-B7 molecule was required [39] The results obtained with the HLA-A2 and B7 anti-H-Y CTLs from the 3rd patient (HLA phenonpe HLA A2 A28, B7. Bw62, Cw3. DR1, ORZ) are shown in table II. As shown in tablc II, cells denved from an HLA-A2-negative, B7-negative femaie donor wcie also lysed, although at a much lower level than was observed for HLA-A2-or B7-positive male target cells Those target cells represent the only discrepancy in the tests with the CTLs from patient 3
Interestingly, Pfeffer and Thorsbv [90] descnbed the detection of HLA-A2-and B7-restncted anti-H-Y CTLs after kidney graft rejection Α prcviously nonsensitized (never transfused or pregnant) femaie patient acutely rejected a kidne\ graft from her HLA-identical brother. Shortly after the graft loss, lymphocytes obtained from the patient showed cytotoxic activity against male target cells shanng the HLA-A2 and (or) B7 antigen with the patient. The latter results and the results which we obtained in our 3 patients suggest that H-Y-specific cytotoxic Τ cells demonstrate preference for certain (ι e A2 and B7) restncting elements.
To gain insight into the apparent dual specificity of such CTLs (A2 plus H-Y, Β7 plus H-Y) at least three basic cellular approaches can be used monolayer absorption, cold target Inhibition and cytotoxic Τ cell clones The results of a cold target Inhibition expenment are shown in HLA-A2-positi\e male taiget cells wcic inhibilcd b\ unlabeled HLA-A2-posime male targei eells bul not b\ unlabeled HLA-B7-positi\e male taiget cells (tablcIH) Eaih C TL subpopulation IS restneted to recogm/ing the foieign antigen (H-\ and olhei minoi Η antigens as will be discussed latci) in association with onh one HLA molcculc Sensiti/ed killer cells which recogni/ed two combincd antigens HLA-A2 Η-Υ and HLA-B7 H-\ could indeed be dmded mio two populations one directed against HLA-A2 ΗΛ and the otheragainst HLA-B7 H-\ The consequence ot these distinct subsets of cytotoxic Τ cells is that the indmdual is not dependent on a Single allele that can sene as a souice of iestnttion molecule for Τ cells Clonal distnbution of HLA-iestncled anti-ΗΛ -specific CTLs has been descnbed also b> Pfeftei and Ihoisln [90] using cold target Inhibition tcsts
Clinual Rele\aiue of the Η-Υ llloantigenic S\stcm
In order to determme the possible influence of H-Y lncompatibihties on the results of human kidnev allogiaft transplantation. we examined cada\ ei ic renal allograft suivnal data (collected under the auspices of Eurotransplant) at 2 years after transplantation for the influence of sex and HLA The retrospective stud> showed a significant difference between HLA-A2 tcmales recei\ing HLA-A2 male kidneys and non-HLA-A2 females recening non-HLA-A2 male kidne>s The H-Y incompatibiliües in donor-iecipient combinations sharing the HLA-A2 antigen resulted in a 38% graft surmal at 2 \ears in contrast to 58% in the HLA-A2 non-shanng group [38] To cxplain these findings and those reported bv Pfeife) and Ihoisln [90] the follovung hypotheses can be considered (1) a peculiar immunofenicit> of the HLA-A2-H-Y complex (and HLA-B7-H-Y complex) (2) tne mvolvcment of Ir genes in the anti-H-Y response Α similar phenomenon has been suggested in the mouse [103] At the moment lt is difficult to choose between these two hypotheses Opel: and Teiasaki [87] investigated the influence of sex on histocompatibility matching in a large senes of kidney transplant recipients They observed a stnking difference in renal allograft survival between the sexes when matching for HLA-A and Β antigens Α highly significant correlation was found between HLA matching and graft survival in male patients Additionally, the latter observation was most stnking in male patients with blood groups other than Ο Some other studies have not been able to detect any influence of sex in kidney transplantation [21, 86] but in those studies male to female transRecogmtion and fmphcation of Human Minor Η Antigens p lanis in HLA.-A2 or HLA-B7-compaiiblc combinations were nol specificalK in\cstigated
In bone marrow transplantation thc Situation IS as follows Despue thc fact that aplastic anemia and leukemia patients are transplanted with bone marrow from an HLA genot\picall\ identical sibhng, rcjection and gratt versus host disease (GVHD) still remain a senous problem in human bone marrow transplantation The results rc >orted on the effcct of se\ match between bone marrow donor and recipient are rather conflicting Stoih et al [110] reported a stud\ of prognostic faetors associated with GVHD and survnal in transplanted aplastic anemia patients. They found that. using a multifactonal anal>sis. thc occurrence of GVHD and survival of patients with aplastic anemia was strongly influenced by whether or not donor and recipient were matched for sex Male patients seemed to have a high mcidence ol GVHD However, the same group [111] recently reported that recipients of marrow from donors of the opposite sex have survivals equal to that of recipients of marrow from sex-matched donors Α pubhcation bv Boitm et al [17] , on the behalf of the Advisory Committee of the International Bone Marrow Transplant Registry, suggested that the use of male donors was preferable to female donors because of a higher rate of engraftment, less severe GVHD and a higher 1-year survival rate. Indeed, investigation of their detailed analysis showed that 64% of male recipients of marrow from female donors had GVHD (male -> female 31 %. female -> female 71 %, male -> male 42%) Additionally, the detailed analysis of the number of 1-year survivors showed that male recipients of bone marrow from female donors had the worst survival rate. In order to obtain a correct insight into the influence of sex combinations on the outcome of bone marrow transplantation, I think the HLA-A2-and B7-positive recipients should be investigated separately. As discussed earher in this chapter, H-Y associated with HLA-A2 and probably also with HLA-B7 seems to act as a streng immunogen in females. In addition, involvement of the HLA-A2 and B7 molecules in associative recogmtion of other minor Η antigens is very strikmg and will be desenbed below.
Class-I-Restncted CTLs Directed against Minor Η Antigens
Simultaneously with the descnption of the estimation of the number of major Η loci in mice, Snell [105] indicated the existence of what he called rare h genes coded for by separate histocompatibihty loci. He noticed at that time the difficulty with which these loci could be detected: 'Is there an> way that these loci can be discovered? The answer would appear that there Ooulmv 36 IS no simple method ot findtng them but that bv thc usc of somcwhat labonous mcthods the\ can e\cntuall\ be brought to light Those Statements are still truc especialh for the human minor Η loci COUIILL et al [20] dassified ihe tissue antigens which aecount for the phenomenon ofgiait rcjcction into two main groups aecording to the strength vwth v.hich the\ lead to graft rejection (1) major Η antigens which cause rapid acute graft rejection and (2) minor Η antigens which aecount tor comparatneh slov\ and more chronic graft rcjections
The minor tiansplantation antigen H-Y coded for bv the \ chiomosome has alread> been discussed above Other minor Η antigens which in mice are coded for bv as marn as 30-100 genetic loci which are spiead all o\er the genome, act more stronglv than others in graft rejection and toi the majontv onh a few allehc forms have been desenbed [58] With Special regard to the cellular recognition of minor Η antigens, Be\an [6-9] extensiv ely anal\zed the cytotoxic T-cell responses towards mmor Η antigens in association with MHC molecules Recentlv considerable Information has been obtained about the possible existence of minor Η antigens in man The oecurrence of a severe GVHD in a bone marrow-transplanted male acute mveloid leukemia patient prompted us to investigate the in vitro cytotoxic activitv of the patient's post-transplantation lymphocytes The patient (HLA phenot\pe HLA-A2, A2, B27, Bw62. Cwl, Cw4 DR1, DR4) had been transplanted with bone marrow from an HLA-identical female sibhng donor and füll chimensm was induced His chnical recovery was compheated bv severe chronic GVHD The initial expenment [42] demonstrated that post-transplant lymphocytes had strong cytotoxic activity. as measured b\ the CML assay, against his ovvn pre-but not post-transplantation lymphoevtes As expected the patient's post-transplant lymphocytes did not react with the target cells from the bone marrow donor Thus, the transplanted lymphocytes (ι c donor cells) differ for a non-HLA factor (which wc designated as minor Η antigen) from the patient's own pre-transplant lymphocytes Subsequently, the patient's post-transplant lymphocytes were anaIy7ed more extensively [44] In order to do so, large quantities of the patient's CTLs were needed They were obtained using the following protocol CTLs with specific cytotoxic activity were generated by stimulatmg the oatient's post-transplant lymphocytes with either his own pre-transplant lymphoevtes or with the lymphocytes from an HLA-A-, B-, C-and DRldentical unrelated healthy individual. After 6 days of pnmary in vitro sensitization, cytotoxic T-cell hnes were grown (by the use of feeder cells Rccogrunon and Implicauun ol Human Minor Η Xnügens GML 03 04
I it; l I \sis pattern in patient s familv plus lectin and/or T-cell growth factor) and were tcsled for specific cvtotoxie activitv and subsequently fro/cn in small ahquots. In that wa\. large amounts of CTLs were harvested. stored and used as typmg rcagents The results obtaincd using as target cclls lymphocytes from (i) ihc patient's own family (2) a comprehensive number of randomh chosen unrelated hcalth> panel donors, and (3) relatives of the positi\el\ Ksed panel donors, are as follows (1) Investigation of patient's familv revealed, besides absence oi tuotoxiciu against the l\,mphocytes of the bone marrow donor (ι e D), dtlterence in succeptibihu to lysis between ULA-nientical siblines (03 04. 05) The latter observation mdicates that we must bc dealing with a non-HLA target determinant (fig 1) (2) The results of the panel stud> are shown in table IV and lllustratc that the non-HLA targel determinants could only be recognized lf onc of the three different HLA class-I molecules of the patient were present on the target cells The panel analysis shows that the minor Η antigen assoeiated with HLA-A2 has high gene frequency in the random population in contrast to the minor Η anligen assoeiated with B27 Neverthcless, we ha\e as The inhibiton capacitv of non labeled target cells carrying only one of the restncting molcculcs plus the minor Η antigen was measured The ratio labeled unlabeled targtl cclls was 1 10 The percentage Ksis for etTector target ratio of 50 1 ts shown The competmve Inhibition protoeol has been desenbed in detail [40] Recogniüon and Imphcation of Human Minor Η Antigens 2 L\sis pallcrn of HLA-restncted anti-minor Η antigen CTLs >et no data to indicate whether or not the non-HLA antigen which IS seen in association with HLA-A2 is the same as those seen in association with HLA-B27 and HLA-Bw62 (3) We investigated the relatives of the positively lysed panel members The family studies showed a codominant mode of inhentance of the HLArestncted minor transplamation antigen In 2 HLA-A/C tross-over families, the target determinant segregated with the HLA-A2 antigen, indicating that ifthis minor Η antigen is coded by chromosome 6, lt is located telomenc from HLA-C An example of the lysis pattern of the HLA-A2-restncted anti-minor Η antigen CTLs in 1 HLA-A/C cross-over family is shown in figure 2 In order to identify the involvement of distinct subsets of CTLs with receptor specificity only for one restncting Clement, cold target competitor expenments and analyses at the clonal level were carned out The results of cold target cell Inhibition expenments (table V) 
Climcal Rele\ance ofthc Minor Η Antigen System
The results in bone marrow transplantation are still far from satisfactory One of the major problems IS GVHD which affects approximateh 50-60% of the patients grafted with bone marrow from HLA-identical Sibljngs Η antigens other than HLA certainly exist. Whether or not thesc non-HLA determinants play a role in the induction of GVHD remains to be proven Results which might be of importance in the understanding of the btological role of non-HLA transplantation Systems and in Us involvcment in organ transplanlation will be discussed below
In the mouse, the involvement of minor Η antigens in GVH reaction has been demonstrated [50, 57, 61-63]. The immunogenetics of GVH reactions to minor Η antigens and vanous properties of cells causing GVHD in mice have lately been summanzed by Korngold and Sprent [64] . Ver> little is known about the factors which might influence the development of GVHD following MHC-identical bone marrow transplantation in man Spaikes et al [107] reported on one such factor a significant correlation was found between compatibihty for the blood group system MNSs between donor and recipient and GVHD. Their results suggested that lncompatibillty for the blood group system MNSs may result in GVHD in man The detcciion ol a non HLA minor Η antigen as dcscubed abo\c piompied us lo continue oui scaich for minoi Η antigens and then iolc in hone manov. tiansplantation The studies weie cained oui in thiec stages In Uu Inst stagc our goal was thc confirmation and evtension ol oui Inst asuhs ic ihe gtneiation of CTLs with post-tiansplant l\mprux\ks ol bone marrow-giaited paticnts and thcir coirelation with the ocunrenee ol CiV HD in thc sccond stage we uscd the in \itro gcnerated c 1 Ls loi ihe tdentihcauon o( other minor Η anugens ι e mcreasing the number ot anti minor Η cellular-t\ping tcag^nts Finalh we used those anti-minoi Η specific CTLs foi thc retrospective t\ping of HLA-identieal bone matrou donor recipicnt pairs Wc studied the post-transplant hmphocues ol 13 HLA-makhed bone manow rccipients " > with no GVHD 7 with acutc GVHD and 4 with thronie GVHD The same culture protocol which was succcsstulK used for generation of anti-minor Η antigen CTLs [42 44 ] was applied Post-transplant hmphocvtes from recipients of HLA genotvpicalK identical bone marrow gratts were sensiti/ed in \itro for 6 da\s with thc patient s pie transplant lymphoc\tes The effector cells harvested at da\ 6 were tested in the C ML assav foi specific c>totoxic acti\ü> The\ were expanded also in ordcr to obtain cvtotoxic T-cell hnes Thus large amounts ol t\toto\ic icagents ma\ be obtained frozen and adequateK used aftcr thawing Table  VII shows thal with post-transplant lymphocUes from D patients 4 ol whom had chronic GVHD evtotoxicity was observed which was dnectcd agamst their own pretransplant l\mphoc>tes
In the second stage we tested the in \itro generated CTLs (dem cd from 5 paticnts) for the identtfication of other minor Η antigens The anahsis of thc c\toto\ic activitv using a limited panel of target cclls trom health\ unrelated indi\ iduals identified five different CTL populations dnected against difterent minor Η antigens The non HL 1 antitftm (designated minor HA.-1 minor HA-2 minor HA-3 minor HA-4 and minor HA-5) and the testiutm% MHC molecules necessar\ for their associatue recognition are shown in table VII The analysis of the CTL 1 (demed from patient 1) recognizing minor HA-1 in association with class-I molecules HLA-A2 B27 and Bw62 have been discussed earher in this chapter and was referred to as minor Η antigen CTLs Another minor Η antigen (ι e minor HA-2) was recognized b> CTL 2 dem cd from patient 2 Our scarch for the restncting molecules bv anah/ing the rvtotoxic activity against a limited number of unrelated target cells has been unsuccessful so far The results obtained with anti-minor HA-3 CTL 3 from patient 3 mdicate that they possibly recognize not only an HLA-A2-restncted non-HLA antigenic determinant but also a non-self-HLA class-I alloantigen (i.c HLA-B8). Thus, HLA-A2 (i.e. selO plus minor HA-3 (i.e. X) equals foreign HLA (i.e. B8). This might be an example of cross-reactivity earher descnbed in mouse [10] Yet, analysis on the clonal level has to be carned out to justify our observation. Recently, cross-reactivity of HLA-restncted Epstein-Barr virus-specific CTLs for allo-MHC determinants has been descnbed [30] Analysis of the reactions of CTL 4 obtained from patient 4 identified other minor Η antigen (i.e. minor HA-4) recognized with the HLA-A2 molecule as restncting element. The HLA-A2-and HLA-Bw44-restncted CTLs denved from patient 5 recognized a minor Η antigen deslgnated minor HA-5. As discussed earlier in this chapter, the minor antigen H-Y IS preferentially recognized in conjunction with the HLA-A2 and B7 molecule. The recognition of different minor Η antigens (i.e. HA-1, HA-3, HA-4 and HA-5 as shown in table VII) demonstrate again the preference for the HLA-A2 class-I molecule for the associative recognition of minor Η antigens In our final thnd stage, the large scale expansion of these minor Hspecific CTLs enabled us to störe enough minor Η reagents in order to The donor iecipient pairs arc selected for the presence ol ihe restncting class I lor required associame recognition ol the minor Η antigens ' No incompdtit»'ities lound belween donor and rccipient Ιοί minor Η \ I to 11 \ b Incompdiibilmcs iund betwecn donor and recipien· for Η4-1 to Η \-·> pro\idc us with t\pmg rcagents Those minor Η c\toto\ic icagents wcie used to type retrospectivcly a senes of HLA-identical bone manow donor recipient pairs recipients without GVHD, recipients with acutc GVHD and recipients with chronic GVHD The results of this anahsis arc shown in tablc VIII. Also shown are the incompatibilities between HLAldentical bone marrow donors and recipients for minor Η antigens found so far mainh in the group of patients suffenng from chronic GVHD
Ρ et specin es
Since donors and recipients are routinely selected for identit\ at the majoi Η System, rejection and GVHD may be caused b\ dispann for the produets of minor Η Systems The effect of weak transplantation antigens on allograft survival may hopefully become predictable when CTL-l\ping reagents at least for the strongest non-MHC transplantation antigens become avaüable At present no alloimmune sera are available, for the typing of the non-HLA antigens, which are relevant in the pathogenesis of GVHD. Consequently, when more than one bone marrow donor IS available (as well in related as in unrelated situations), CTL typing may mitigate at least one of the obstacles for successful bone marrow transplantation Our present goals are. (1) the generation of anti-minor Η CTLs with post-
